Systemic anticoagulation considerations in chronic kidney disease.
about
Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current EvidenceMulticenter trial of desirudin for the prophylaxis of thrombosis: an alternative to heparin-based anticoagulation (DESIR-ABLE).Anticoagulation Therapy in Patients with Chronic Kidney Disease.Role of factor xa inhibitors in cancer-associated thrombosis: any new data?Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparinA novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy.Renal profiles of anticoagulants.How to prevent, treat, and overcome current clinical challenges of VTE.Dabigatran: is there a role for coagulation assays in guiding therapy?Novel oral anticoagulants for stroke prevention in the geriatric population.Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerationsRisk of pulmonary embolism in patients with end-stage renal disease receiving long-term dialysis.Effects of citrate-enriched bicarbonate based dialysate on anticoagulation and dialyzer reuse in maintenance hemodialysis patients.Can enoxaparin be used safely in end-stage renal disease?Primary Prevention of Stroke in Chronic Kidney Disease Patients: A Scientific Update.Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial.
P2860
Q26782483-D8AED47D-357A-42C7-9324-0716B2ABFF91Q33402370-9BA36846-6D77-4AE8-A258-6B5509228762Q33435357-4FE9C7AC-C699-45DF-8C68-CF0F0D9F8907Q34052232-6F4ED13C-FD46-4FF4-A971-D6D3402ED74DQ34122392-8E75381D-5979-43C1-8330-0E87F75DFCB6Q34318898-0C3DB5C2-F46D-4234-A56B-DF70F86B93CAQ37879330-EF481071-BA65-4095-8143-EDD5C3F11DB5Q37903951-B2017C0F-4EEF-4843-8F61-CEB9E9BB67D6Q38106833-603121E6-E7BD-4FBE-8CE5-3A141370A3D2Q38162796-35EBCBD2-3476-4285-95CA-5DC4650FE970Q38707885-FD82AEFB-9329-4E79-84C0-49694B6592ECQ39569545-6DB87E2B-8A6C-4876-A14C-0681E6B90281Q43450340-F1A1A3F6-6201-472D-A7C8-3BF664DB1637Q46094670-854026DB-A8AE-48B1-A701-E73F7ED922DEQ47188294-68BE9AD0-1B95-4D50-ADEC-2511C9ADDB91Q53791589-4E6863A7-D75B-4815-937E-C9B75B4D3B5C
P2860
Systemic anticoagulation considerations in chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic anticoagulation considerations in chronic kidney disease.
@en
Systemic anticoagulation considerations in chronic kidney disease.
@nl
type
label
Systemic anticoagulation considerations in chronic kidney disease.
@en
Systemic anticoagulation considerations in chronic kidney disease.
@nl
prefLabel
Systemic anticoagulation considerations in chronic kidney disease.
@en
Systemic anticoagulation considerations in chronic kidney disease.
@nl
P1476
Systemic anticoagulation considerations in chronic kidney disease
@en
P2093
William E Dager
P304
P356
10.1053/J.ACKD.2010.06.002
P577
2010-09-01T00:00:00Z